ResMed (RMD)
(Delayed Data from NYSE)
$197.04 USD
-11.30 (-5.42%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $197.20 +0.16 (0.08%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth C Momentum B VGM
Earnings News For RMD
-
ResMed (RMD) Reports Next Week: Wall Street Expects Earnings Growth
-
ResMed to Report Fourth Quarter Fiscal 2024 Earnings on August 1, 2024
-
ResMed (RMD) Q3 Earnings Beat Estimates, Margins Expand
-
ResMed (RMD) Q3 Earnings and Revenues Surpass Estimates
-
ResMed: Fiscal Q3 Earnings Snapshot
-
ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2024
-
ResMed (RMD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
-
ResMed to Report Third Quarter Fiscal 2024 Earnings on April 25, 2024
-
Why Is ResMed (RMD) Down 1.7% Since Last Earnings Report?
-
ResMed (RMD) Q2 Earnings Beat Estimates, Margins Expand
-
ResMed: Fiscal Q2 Earnings Snapshot
-
ResMed (RMD) Tops Q2 Earnings and Revenue Estimates
-
ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2024
-
ResMed to Report Second Quarter Fiscal 2024 Earnings on January 24, 2024
-
ResMed (RMD) Q1 Earnings Surpass Estimates, Margins Down
-
ResMed (RMD) Beats Q1 Earnings and Revenue Estimates
-
ResMed: Fiscal Q1 Earnings Snapshot
-
ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2024
-
ResMed (RMD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
-
ResMed to Report First Quarter Fiscal 2024 Earnings on October 26, 2023
-
ResMed's (RMD) Q4 Earnings Miss, Revenues Beat Estimates
-
ResMed (RMD) Misses Q4 Earnings Estimates
-
ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2023
-
ResMed to Report Fourth Quarter Fiscal 2023 Earnings on August 3, 2023
-
ResMed (RMD) Q3 Earnings and Revenues Surpass Estimates